Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting

Annals of Pharmacotherapy

Volumn 43, Issue 2, 2009, Pages 339-346

  Gómez, Marciana Alodia ^a   Villafaina, Antonio ^b   Hernández, Jesús ^a   Salgado, Rosa María ^b   González, Miguel Ángel ^a   Rodríguez, Jesús ^a   De La Concha, Manuel Martínez ^b   Tarriño, Alejandra ^b   Gervasini, Guillermo ^c   Carillo, Juan Antonio ^c  

^a Centro de Salud de Olivenza   (Spain)

^b Centro de Salud de San Vicente de Alcántara   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Drug related problems; Polypharmacy

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESISTANCE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICATION ERROR; METABOLIC DISORDER; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PHARMACIST ATTITUDE; POLYPHARMACY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; COMMUNITY PHARMACY SERVICES; DRUG TOXICITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PRESCRIPTION DRUGS; PRIMARY HEALTH CARE; SPAIN;

EID: 60349109599     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L242     Document Type: Article

References (30)

1. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990;24:1093-7.
2. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67. Epub 30 Mar 2004. DOI 10.1345/aph.1D182
3. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120-7.
4. Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 2006;28:61-4. DOI 10.1007/s11096-006-9008-8
5. Vínks TH, de Koning FH, de Lange TM, Egberts TC. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 2006;28:33-8. DOI 10.1007/s11096-006-9008-8 DOI 10.1007/s11096-005-4213-4
6. Pharmaceutical Care Research Group and Pharmacology Research Group UoG. Consensus of Granada on Drug Related Problems. Pharm Care Esp 1999;1:107-12.
7. Pharmaceutical Care Research Group and Pharmacology Research Group UoG. Second Consensus of Granada on Drug Related Problems. Ars Pharm 2002;43:175-84.
8. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000;25:355-61. DOI 10.1046/j.1365-2710.2000.00298.x
9. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54. DOI 10.1023/A:1015570104121
10. Ong SW, Fernandes OA, Cesta A, Bajcar JM. Drug-related problems on hospital admission: relationship to medication information transfer. Ann Pharmacother 2006;40:408-13. Epub 21 Feb 2006. DOI 10.1345/aph.1G482
11. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11. DOI 10.1093/ageing/30.3.205
12. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des 2004;10:3987-4001.
13. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695-700. DOI 10.2174/1381612043382576
14. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007;7:9. DOI 10.1186/1472-6904-7-9
15. Easton KL, Chapman CB, Brien JA. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 2004;57:611-5. DOI 10.1111/j.1365-2125.2003.02052.x
16. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997;26:375-82. DOI 10.1093/ageing/26.5.375
17. Hitchen L. Adverse drug reactions result in 250,000 UK admissions a year. BMJ 2006;332:1109. DOI 10.1136/bmj.332.7550.1109
18. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002;22:915-23. DOI 10.1592/phco.22.11.915. 33630
19. Ayani I, Aguirre C, Gutierrez G, Madariaga A, Rodriguez-Sasiain JM, Martinez-Bengoechea MJ. A cost-analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol Drug Saf 1999;8:529-34. DOI 10.1002/(SICI)1099-1557(199912)8:7〈529::AID-PDS460〉3.0.CO;2-J
20. Baena Parejo MI, Faus Dader MJ, Marin Iglesias R, Zarzuelo Zurita A, Jimenez Martin J, Martinez Olmos J. [Health related problems as cause of visits to hospital emergency departments] Spanish. Med Clin (Barc) 2005;124:250-5.
21. Lyra DP Jr, Rocha CE, Abriata JP, Gimenes FR, Gonzalez MM, Pela IR. Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients. Patient Educ Couns 2007;68:186-92. DOI 10.1016/j.pec.2007.06.004
22. Rao D, Gilbert A, Strand LM, Cipolle RJ. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci 2007;29:647-54. DOI 10.1007/s11096-007-9123-1
23. Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 2004;26:353-60. DOI 10.1007/s11096-004-2268-2
24. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999;21:245-50.
25. Leemans L, Veroeveren L, Bulens J, et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci 2003;25:65-9.
26. Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Investig 2006; 26:415-25. DOI:10.2165/00044011-200626070-00003
27. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003;169:17-22.
28. Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess 2002;6:1-86. DOI 10.1136/bmj.323.7325.1340
29. Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 2005;1:39-48. DOI 10.2147/term.1.1.39.53597
30. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999;55:533-6. DOI 10.1007/s002280050669